Pro-Dex Inc is primarily active in the medical device industry.

The main competitors of Pro-Dex Inc in the market include companies such as Danaher Corporation, Intuitive Surgical Inc, and Medtronic plc.

Pro-Dex Inc., a leading technology company, has a rich history and background. Founded in 1978, it has emerged as a prominent player in the manufacturing industry. Pro-Dex specializes in designing and producing high-quality motion control systems and precision instruments. With a strong focus on innovation and customer satisfaction, the company has established a global presence in various sectors including medical, aerospace, and dental. Pro-Dex Inc. is committed to providing cutting-edge solutions through continuous research and development. Its dedication to excellence and customer-centric approach has propelled Pro-Dex Inc. to become a trusted name in the industry.

Pro-Dex Inc, a leading company in the stock market, has achieved several significant milestones. From its inception, Pro-Dex Inc has been dedicated to providing innovative solutions to various industries. Over the years, the company has successfully diversified its product portfolio, offering cutting-edge technologies and superior performance. Pro-Dex Inc has also demonstrated consistent growth, expanding its market presence and surpassing industry expectations. Additionally, the company has successfully established strong partnerships and collaborations, enabling it to enhance its product offerings and drive further success. Pro-Dex Inc's commitment to excellence and its ability to adapt and evolve have contributed to its remarkable achievements and positioned it as a top contender in the market.

Pro-Dex Inc is primarily present in the United States.

Pro-Dex Inc represents a set of core values and a corporate philosophy focused on innovation, quality, and customer satisfaction. With a commitment to excellence, Pro-Dex Inc strives to deliver cutting-edge technology and solutions in the areas of motion control, medical devices, and robotics. The company aims to meet and exceed customer expectations by continuously improving its products and services, while also fostering a culture of integrity, teamwork, and respect. Pro-Dex Inc's dedication to innovation and customer-centric approach sets it apart in the market, driving its growth and success in the industry.

Analysts currently set an average price target of 57,12 USD for the Pro-Dex stock (median: 57,12 USD), implying −14,9 % versus the latest price. The consensus is based on 7 analyst ratings.

Pro-Dex Analyytikkojen kursstavoitteet 2026

7 analysts currently rate the Pro-Dex stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Pro-Dex to generate revenue of 76,40 M USD and earnings per share of 4,01 USD.

Pro-Dex Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the Pro-Dex share trades at 58,23 EUR (67,11 USD).

The Pro-Dex share (PDEX) is listed on 2 stock exchanges, including: NASDAQ (PDEX), Frankfurt (PDXN.F).

Pro-Dex Inc is a company specializing in the development and manufacturing of high-precision components and instruments for medical and dental applications. Their business model is based on three main segments: medical technology, dental technology, and industrial technology. They offer a wide range of products in the medical technology field, such as surgical instruments, catheters, endoscopes, and other medical devices. In the dental technology sector, they produce precision instruments for dentists worldwide. And in the industrial technology segment, they provide precision components for various industries, including aerospace, automotive, electronics, and more. Their business model focuses on high manufacturing competence, innovative solutions tailored to customer needs, and a strong emphasis on quality. They work closely with their customers to meet the high standards required in the medical, dental, and industrial fields.

odotettu liikevaihto Pro-Dex on 76,40 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Pro-Dex on 13,24 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Pro-Dex:n hinta-voitto-suhde (P/E) on tällä hetkellä 16,75. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Pro-Dex-osakkeen arvostusta.

Pro-Dex:n hinta-myynti-suhde (P/S) on tällä hetkellä 2,90. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Pro-Dex-osakkeen arvostuskennuslukuna.

Pro-Dex:n Eulpool-laatuscore on 7/10.

Pro-Dex:n ISIN on US74265M2052. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Pro-Dex:n WKN on A1C0JP. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Pro-Dex:n ticker on PDEX. Tämä pörssinoteeraus käytetään Pro-Dex-osakkeiden kauppaan pörssissä.

Pro-Dex maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

Pro-Dex kuuluu sektoriin 'Terveydenhuolto'.

Pro-Dex:n osingot jaetaan valuutassa USD.